PHARMA-BIO SERV, INC. Share-based Payment Arrangement, Expense, after Tax
PHARMA-BIO SERV, INC. (PBSV) reported Share-based Payment Arrangement, Expense, after Tax of $35.08 thousand for the 12-month period ending 2025-10-31, per its 10-K filed 2026-01-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax · last filed 2026-01-29
- PHARMA-BIO SERV, INC. share-based payment arrangement, expense, after tax for fiscal 2025 was $35.08K, a 26.22% decline from fiscal 2024.
- PHARMA-BIO SERV, INC. share-based payment arrangement, expense, after tax for fiscal 2024 was $47.55K, a 5.46% increase from fiscal 2023.
- PHARMA-BIO SERV, INC. share-based payment arrangement, expense, after tax for fiscal 2023 was $45.08K, a 37.07% decline from fiscal 2022.
- PHARMA-BIO SERV, INC. share-based payment arrangement, expense, after tax for fiscal 2022 was $71.64K, a 27.39% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense, after Tax 12 month |
|---|---|
| 2025-10-31 | $35.08K 10-K · filed 2026-01-29 |
| 2024-10-31 | $47.55K 10-K · filed 2026-01-29 |
| 2023-10-31 | $45.08K 10-K · filed 2025-01-29 |
| 2022-10-31 | $71.64K 10-K · filed 2024-01-29 |
| 2021-10-31 | $56.24K 10-K · filed 2023-01-30 |
| 2020-10-31 | $42.88K 10-K · filed 2022-02-11 |
| 2019-10-31 | $34.12K 10-K · filed 2021-02-01 |
| 2018-10-31 | $51.64K 10-K · filed 2020-01-29 |
| 2017-10-31 | $63.88K 10-K · filed 2019-01-29 |
| 2016-10-31 | $88.88K 10-K · filed 2018-01-29 |
| 2015-10-31 | $87.12K 10-K · filed 2017-01-31 |
| 2014-10-31 | $94.40K 10-K · filed 2016-01-29 |
| 2013-10-31 | $53.16K 10-K · filed 2015-01-29 |
| 2012-10-31 | $23.66K 10-K · filed 2014-01-29 |
| 2011-10-31 | $8.66K 10-K · filed 2013-01-29 |